SARS-CoV-2 prevalence in an asymptomatic cancer cohort - results and consequences for clinical routine

BACKGROUND: Starting in December 2019, the current pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) confronts the world with an unprecedented challenge. With no vaccine or drug being currently available to control the pandemic spread, prevention and PCR (Polymerase...

Descripción completa

Detalles Bibliográficos
Autores principales: Marschner, Sebastian, Corradini, Stefanie, Rauch, Josefine, Zacharias, Richard, Sujic, Ana, Mayerle, Julia, Petru, Raluca, Grabein, Béatrice, Keppler, Oliver T., Boelke, Edwin, Belka, Claus, Niyazi, Maximilian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7344028/
https://www.ncbi.nlm.nih.gov/pubmed/32646505
http://dx.doi.org/10.1186/s13014-020-01609-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7344028/
https://www.ncbi.nlm.nih.gov/pubmed/32646505
http://dx.doi.org/10.1186/s13014-020-01609-0

Ejemplares similares